Chronic rhinosinusitis (CRS) is a heterogeneous condition characterised by persistent sinus 24 inflammation and microbial dysbiosis. This study aimed to identify clinically relevant sub-25 groups of CRS patients based on distinct microbial signatures, with a comparison to the 26 commonly used phenotypic subgrouping approach. The underlying drivers of these distinct 27 microbial clusters were also investigated, together with associations with epithelial barrier 28 integrity. 29
Introduction 63
As the first line of defence against inhaled antigens from the external environment, the upper 64 airway epithelium represents an important physiological barrier (1). Maintaining the close 65 cell to cell proximity that is central to the integrity of this barrier are tight junctions, which 66 play a critical role in host defence (2, 3). Tight junctions comprise a range of transmembrane 67 and scaffolding adaptor proteins that include occludin, claudins, junctional adhesion 68 molecules, and zonula occludens (ZO) (4). These proteins limit the passage of 69 macromolecules by sealing off the paracellular spaces between epithelial cells. On the other 70 hand, in cases of tissue inflammation, the opening up of tight junctions assists in the release 71 of tissue fluids and the influx of inflammatory cells and by doing so helps speed resolution. 72
Accordingly, tight junctions are considered as the gatekeepers of inflammatory disease. 73
Recent studies have considered the role of epithelial barrier defects in a number of chronic 74 inflammatory conditions, including chronic rhinosinusitis (CRS) (5, 6). CRS is an 75 inflammatory condition of the upper respiratory tract persisting for over 12 weeks, affecting 76 5% of the general population (7). Symptoms include nasal discharge, facial pain, loss of 77 smell and headaches. CRS is a complex and heterogeneous disease, with many underlying 78 factors that present with similar symptoms, making it challenging to separate CRS into 79 clinically relevant subtypes. Traditionally, classification of CRS has been based on the 80 clinical phenotypesthe presence (CRSwNP) or absence (CRSsNP) of polyposis. 81
Approximately 25-30% of CRS patients present with nasal polyps (8), and this cohort is 82 considered to have a Th2-predominated inflammatory response compared with idiopathic 83 CRS without nasal polyps (CRSsNP) that has Th1-type responses. However, this simplified 84 view misrepresents the true complexities of CRS. 85
Recent efforts have investigated the pathogenesis of CRS based on inflammatory markers (9, 86 10), microbiota composition (11, 12), pathology or clinical factors (13, 14) , but these studies 87 5 have produced little consensus on appropriate strategies to subtype patients. The role of 88 microbes in CRS remains unclear due to the frequent lack of resolution with antimicrobial 89 treatment. It has been suggested that a loss of overall microbiota diversity and deleterious 90 community changes (collectively termed 'dysbiosis') are more characteristic of CRS patients 91 than a single, disease-causing organism (15) . 92
Stratification of patients based on probabilistic modelling of the bacterial communities in 93 lower respiratory diseases such as asthma and HIV-infected pneumonia patients has been 94 used successfully to classify immunological or clinical phenotypic variation across cohorts 95 (16, 17) . Using a similar approach, a recent study subtyped CRS patients based on their 96 microbial community profiles (11). Each distinct microbial state was dominated by one 97 bacterial family and associated with a unique clinical and host immune response. Previous 98 studies have found that large interpersonal variations in the sino-nasal microbiome of CRS 99 patients (subtyped based on clinical diagnosis) can make classification difficult (12). 100 Accordingly, a distinct advantage of stratifying patients based on microbial community 101 profiles is that it will help to resolve the microbial heterogeneity of CRS and is a step towards 102 implementation of a precision medicine approach. The underlying drivers of these distinct 103 microbial states in CRS are yet to be investigated. 104
Several studies have investigated epithelial integrity in CRS mucosa and found that CRS 105 patients with nasal polyps (CRSwNP) have severely disrupted epithelia with decreased 106 expression of occludin and ZO-1 (6, 18, 19). These efforts also suggest a role for cytokines 107 (IFN-γ and IL-4) in disrupting tight junctions, whereas the influences of the microbes on the 108 host are less understood. 109
One common hypothesis is that a loss of tight junction integrity in CRS patients could lead to 110 the entry of environmental agents, including microbes, into host tissues (20). It remains 111 unclear whether the microbes are the cause of tissue damage or if microbial patterns or 6 associations are the consequence of a leaky epithelium, leading to a build-up of microbial 113 cells in the tissue. The mechanism by which bacteria penetrate the epithelial barrier is 114 unknown, but their presence in CRS tissue (in particular CRS with cystic fibrosis (CRSwCF)) 115 presumably reflects a breakdown in mucosal integrity (21). Furthermore, any changes caused 116 to the micro-environment (such as lack of mucociliary clearance, damaged surfaces for 117 bacterial cell adherence) could have an impact on microbial composition and structure, as 118 observed previously in gut studies (22) . 119
In this study, we aimed to stratify CRS patients based on their microbial community 120 composition using a probabilistic modelling approach and using the traditional phenotypic 121 approach. In addition, we investigated several possible underlying influences on these 122 microbial states by measuring gene and protein expressions of host tight junction, epithelial 123 integrity and inflammatory cells (T-cells, B-cells, and macrophages) in the sino-nasal tissue 124 biopsies. 125 126 127
Results

128
Clinical parameters 129
Non-parametric pairwise comparisons were made based on clinical factors in this cohort of 130 31 subjects (CRS = 23, disease controls = 8). Patient demographics are included in Table S1 . 131
Dirichlet multinomial mixtures using probabilistic modelling in R were used to stratify 132 patients based on their microbial communities (operational taxonomic unit (OTU)-level) (23). 133
The Laplace approximation was used to find the model of best fit and determine the number 134 of clusters from the dataset. Unique microbial states were labelled Dirichlet clusters (DC). 135
None of the measured clinical factors were significantly different between the two DC groups 136 (DC1 and DC2) and disease controls (Table S2 ). A similar analysis was performed on 7 phenotypic subtypes of CRS (CRSsNP, CRSwNP, CRSwCF) and disease controls (Table  138 S3), where age and polyposis were found to be significant factors. A variety of alpha-diversity measurements revealed significant differences between DC1 and 159 controls, however no significant differences were noted between DC1-DC2 and DC2-controls 160 (Fig. 1B) . The bacterial taxa Pseudomonas (average relative abundance 19% ± SD 37%), 161 Achromobacter (7.6% ± SD 27%), and Haemophilus (8.5% ± SD 27%) dominated DC1, 162 8 while DC2 was dominated by Moraxella (18% ± SD 31.5%) and Stenotrophomonas (6.7% ± 163 SD 17.7%), but these taxa all had low prevalence as shown in Fig. 2B . Interestingly, controls 164 were not dominated by any single bacterial taxon but instead had a low abundance of 165 multiple genera, some of which were highly prevalent. 166
Taxa that were significantly different between groups were investigated through multiple 167 pairwise comparisons at OTU-and genus-level ( The dispersion of samples based on microbial community profiles in each DC was compared 174 by calculating the distances to the centroid in non-metric multidimensional scaling (nMDS) 175 analyses. DC1 samples were significantly more dispersed than control samples (p = 0.011, 176
Tukey's honest test) ( Fig. 3B ). In addition, Permutational Multivariate Analysis of Variance 177 (PERMANOVA) test confirmed that each of the clusters identified for the CRS cohort and 178 control group explained a significant proportion (R 2 = 12.2%, p = 0.014) of the overall 179 variation in the bacterial dataset. However these PERMANOVA results should be interpreted 180 with caution in light of the different beta-dispersion patterns of the groups assessed (24). 181 182
Bacterial community composition of phenotypic groups 183
Patients were also stratified based on clinical presentation of the disease, which includes the 184 presence or absence of nasal polyposis and comorbidity of cystic fibrosis. 185
Alpha diversity was significantly (p <0.001) lower in CRSwCF patients compared with 186 controls. Significant differences in diversity were also observed (p <0.05) between CRSwCF 187 and CRSwNP samples. 188
Similar to controls (as described above), CRSsNP did not show dominance of any single 189 bacterial taxon. However CRSwNP samples were dominated by Moraxella (average relative 190 abundance 16% ± SD 30%) and Stenotrophomonas (5.8% ± 16.5%), while CRSwCF samples 191 were dominated by Pseudomonas (35.4% ± 46%), Staphylococcus (24.5% ± 41.6%), 192
Achromobacter (14.1% ± 37%), and Haemophilus (13.9% ± 36.8%) ( Veillonella, compared to controls. OTUs and genera that were significantly different between 199 CRS subtypes can be found in Table S5 . 200
There were no significant differences in dispersion between phenotypic groups and controls 201 when calculating analysis of variance. However, PERMANOVA tests were able to explain a 202 larger proportion of the variation (R 2 = 23.4%, p = 0.001) by phenotypic subtyping methods 203 for CRS than with DC clustering. 204 205
Tight junction protein and gene expression patterns in sino-nasal tissue 206
Based on our initial aim to investigate the underlying drivers of each subtype in CRS, the 207 expression of 42 tight junction genes in sino-nasal tissue biopsies was measured for each 208 patient and compared to that of disease controls. After results were normalised to a 209 housekeeping gene, fold-changes in gene expression were recorded for each DC and CRS 210 phenotypic subtype compared to controls. 211
Ten tight junction genes were significantly under-or over-expressed in DC1 and/or DC2 212 compared to controls (Fig. 4A ). The gene ACTA1, which encodes a skeletal α-actin protein 213 that maintains the cytoskeleton and cell movement, was the only gene to be significantly 214 over-expressed in both DC1 and DC2. Each DC group exhibited unique tight junction gene 215 expression patterns. Three genes were significantly under-expressed in DC1: CSDA, TCF7 216 and PVRL1. In DC2, nine genes were significantly under-expressed compared with controls 217
Subtyping patients based on phenotypic characteristics found 7 tight junction genes to be 219 under expressed and ACTA1 gene to be over expressed in the CRS cohorts compared with 220 the controls ( Fig 4B) . Genes PVRL1 and TCF7 were significantly under-expressed in all 221 three CRS subtypes. The expression profile of CRSsNP and CRSwCF were very alike, with 222 the only one exception (gene CSDA) which was under-expressed in CRSwCF patients 223 ( Fig. 4B ). Spearman correlation analysis of the dataset after adjustment for multiple 224 comparisons showed a significant negative association between tight junction gene MTDH 225 expression and members of the bacterial genus Pseudomonas (Fig. S1 ). 226
Staining of sino-nasal tissue biopsies identified ZO-1 and occludin proteins at apico-lateral 227 contact points of adjacent epithelial cells ( Fig. S2 ). Claudin-1, by contrast, was 228 predominantly seen in subapical regions, with concentrated, continuous staining amongst the 229 mid-basal region of epithelial cells (Fig. S2 ). ZO-1 area staining was significantly (p = 0.03) 230 lower in DC2 (mean 0.5 ± S.D 0.3%) compared with controls (1.1 ± 0.5%) (Table S3 ). There 231 were no significant differences in claudin-1 and occludin staining in disease controls relative 232 to DC1 and DC2. In addition, there were no significant differences in the staining of ZO-1, 233 claudin-1 and occludin proteins in the three CRS subtypes compared with controls. 234 Furthermore, no correlations were observed between tight junction proteins and abundance of 235 bacterial taxa (Fig. S1 ). 236 237
Inflammatory state and mucosal integrity of tissue biopsies 238
Inflammatory marker cells (T-cells, B-cells and macrophages) were enumerated in the tissue 239 biopsies to assess the inflammatory state of the patients. Although all three cell types were 240 reduced in the disease controls compared with DC1 and DC2 cohorts, B-cells (CD20+) were 241 the only identified inflammatory marker with a significant difference between the groups, 242 with higher numbers in DC2 (Table S2) . 243
In contrast, by traditional CRS subtyping approaches, all three inflammatory marker cells 244
were significantly elevated only in CRSwNP cohort compared with controls. There were no 245 significant differences between the CRS sub-type cohorts, except for the elevated amounts of 246 macrophages (CD68+) in CRSwNP compared with CRSwCF. 247
The sino-nasal tissue biopsies were also assessed for mucosal integrity. Goblet cell 248 enumeration and cilia integrity in the biopsy specimens were significantly reduced in DC2 249 compared with DC1 and control (Table S2) . Similarly, when subtyping the same group of 250 patients based on phenotypic approaches, goblet cell enumeration and cilia integrity were 251 significantly reduced in CRSwNP patients compared with controls and CRSsNP patients. 252
Interestingly, CRSwCF patients had no significant differences in mucosal integrity (collagen 253 content, goblet cell enumeration and cilia integrity) compared with controls. Furthermore, 254
Spearman correlation analysis showed a positive association between goblet cell counts and 255 tight junction gene LEF1 expression ( Fig. S1 ). No other significant associations were found 256 between mucosal integrity, inflammatory marker cells and all other measured variables in this 257 study. 258 259 Discussion 261
Endotyping of CRS patients has been the subject of considerable recent research, as it is 262 hoped that a sub-classification of this condition will allow for more specific and effective 263 therapies to be administered. In this study, we defined microbial states for CRS using 264 probabilistic modelling, in which patients with similar microbial states were clustered 265 together. Furthermore, the same cohort of patients were also sub-typed based on phenotypic 266 presentation of the disease. We then sought to understand the underlying influences on these 267 cohorts by investigating sino-nasal mucosal integrity, tight junction gene/protein expression 268 and inflammatory status. The two approaches of clustering CRS patients will be compared 269 and discussed further. (11) is that it reflects a patient's microbial state at the time and places the patient into a 278 distinct microbial cluster type. Appropriate targeted treatment strategies could then be 279 prescribed for patients in the future based on their distinct microbial pattern. 280
In this study, two distinct microbial states of CRS patients were identified that were 281 significantly different to each other in diversity, beta-dispersion and the relative abundance of 282 members from the genus Anaerococcus. Although this novel way of classifying CRS samples 283 could explain some of the microbial variations in the dataset, there was still a large 284 13 proportion of variation that could not be accounted for. This is most likely due to the sizeable 285 inter-patient variation observed in this study and reported previously (15, 25). We anticipate 286 with larger cohort sizes these microbial states would be more pronounced and less obscured 287 by individual variation. While studies that use less invasive approaches to obtain samples 288 such as nasopharyngeal swabs and rinses are able to increase cohort sizes (26, 27), these 289 samples are not suitable for analyses of histology and mucosal integrity. In addition, tissue 290 biopsies are required to study host gene expression levels. For these reasons, tissue biopsies 291 were used in the analyses within this study. 292
Subtyping patients based on the phenotype of the disease (with or without nasal polyps or 293 with cystic fibrosis) has been the most common approach to date. The results of the microbial 294 communities from each of these subtypes is confirmatory to those previously described by 295 our group (28, 29). Interestingly, a greater amount of the variation (23.4%) observed in the 296 dataset from this study could be explained through this patient phenotypic clustering 297 approach rather than by the DC approach. 298 299
Potential drivers of microbial signatures for CRS patients 300
Understanding the underlying factors that shape the sino-nasal microbial community of a 301 CRS patient is essential for defining the pathogenesis of this complex disease and for 302 developing better treatment protocols. The most common hypothesis for the pathogenesis of 303 CRS is that the epithelial barrier is defective (30). Allergens (such as pollen), host genetics, 304 bacteria, viruses or inflamed tissue could all contribute to the disruption of the sino-nasal 305 epithelial barrier (31). In this study, we chose to investigate several of these potential host 306 factors that could contribute to CRS pathogenesis and determine their influence on the sino- biopsies of CRS patients has been found previously (6, 34). The lack of any significant 334 observations on the tight junction protein measurements in the phenotypic CRS sub groups 335 compared with controls, also emphasises the need to look at other ways to stratify CRS. 336
Another potential driver of microbial states in CRS is mucosal integrity. Several studies have 337 reported significant changes in the structure and composition of the mucosa in CRS (35-37). 338 CRS subjects exhibited polarising results in regards to evidence of mucus hypersecretion, 339 with a significantly higher goblet cell count compared with controls. Interestingly, DC2 The traditional approach of stratifying CRS patients based on their phenotypic presentation of 367 the disease is standard practice, however such approaches are struggling to unravel the 368 complexities of the disease. This study showed that, while phenotypic subtyping approaches 369 can help explain some of the variation in the microbial community dataset, alternative 370 methods using microbial signatures can also have some benefit. Each microbial state of CRS 371 in this study was found to have a unique tight junction expression profile, which was not 372 observed for the phenotypic subtyping approach. Accordingly, it remains unclear whether 373 microbial states influence, or are being influenced by, barrier impairment. To answer these 374 questions, in vitro studies will need to be undertaken in the future. Patients completed a symptom score sheet, prior to surgery, in which the following CRS 393 symptoms were rated on a scale of 0-5: nasal obstruction, anterior nasal discharge, posterior 394 nasal discharge, facial pain or fullness, and loss of smell. These scores were summated to 395 give the 'Symptom Severity' score in Table S1 . Lund-Mackay scoring was used to quantify 396 radiological disease severity (45). Tissue biopsies were collected intraoperatively from the 397 ethmoidal sinus under general anaesthesia prior to administration of topical vasoconstrictors 398 or intravenous antibiotics. Biopsied specimens were rinsed in sterile saline and partitioned. 399
Samples for quantitative PCR and bacterial community analysis were fixed in RNAlater for 400 24 h, then stored at -20°C. Samples for immunohistochemistry analysis were fixed in 401 
